Your browser doesn't support javascript.
Health outcomes of patients with type 2 diabetes following bariatric surgery: Results from a publicly funded initiative.
O'Moore-Sullivan, Trisha; Paxton, Jody; Cross, Megan; Teppala, Srinivas; Chikani, Viral; Hopkins, George; Wykes, Katie; Scuffham, Paul A.
  • O'Moore-Sullivan T; Medical and Chronic Disease Services, Mater Health, Brisbane, Queensland, Australia.
  • Paxton J; Healthcare Improvement Unit, Clinical Excellence Queensland, Queensland Health, Brisbane, Queensland, Australia.
  • Cross M; Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
  • Teppala S; Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
  • Chikani V; Department of Diabetes and Endocrinology, The Princess Alexandra Hospital, Brisbane & Senior Lecturer, University of Queensland, Brisbane, Queensland, Australia.
  • Hopkins G; Royal Brisbane and Womens Hospital, Queensland Health, Brisbane, Queensland, Australia.
  • Wykes K; Healthcare Improvement Unit, Clinical Excellence Queensland, Queensland Health, Brisbane, Queensland, Australia.
  • Scuffham PA; Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.
PLoS One ; 18(2): e0279923, 2023.
Article in English | MEDLINE | ID: covidwho-2284523
ABSTRACT

OBJECTIVE:

Bariatric surgery is an effective treatment for type 2 diabetes and morbid obesity. This paper analyses the clinical and patient-reported outcomes of patients treated through the Bariatric Surgery Initiative, a health system collaboration providing bariatric surgery as a state-wide public service in Queensland, Australia. RESEARCH DESIGN AND

METHODS:

A longitudinal prospective cohort study was undertaken. Eligible patients had type 2 diabetes and morbid obesity (BMI ≥ 35 kg/m2). Following referral by specialist outpatient clinics, 212 patients underwent Roux-en-Y gastric bypass or sleeve gastrectomy. Outcomes were tracked for a follow-up of 12-months and included body weight, BMI, HbA1c, comorbidities, health-related quality of life, eating behaviour, and patient satisfaction.

RESULTS:

Following surgery, patients' average body weight decreased by 23.6%. Average HbA1c improved by 24.4% and 48.8% of patients were able to discontinue diabetes-related treatment. The incidence of hypertension, non-alcoholic steatohepatitis, and renal impairment decreased by 37.1%, 66.4%, and 62.3%, respectively. Patients' emotional eating scores, uncontrolled eating and cognitive restraint improved by 32.5%, 20.7%, and 6.9%, respectively. Quality of life increased by 18.8% and patients' overall satisfaction with the treatment remained above 97.5% throughout the recovery period.

CONCLUSIONS:

This study confirmed previous work demonstrating the efficacy of publicly funded bariatric surgery in treating obesity, type 2 diabetes and related comorbidities, and improving patients' quality of life and eating behaviour. Despite the short follow-up period, the results bode well for future weight maintenance in this cohort.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Obesity, Morbid / Gastric Bypass / Laparoscopy / Diabetes Mellitus, Type 2 / Bariatric Surgery Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2023 Document Type: Article Affiliation country: Journal.pone.0279923

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Obesity, Morbid / Gastric Bypass / Laparoscopy / Diabetes Mellitus, Type 2 / Bariatric Surgery Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2023 Document Type: Article Affiliation country: Journal.pone.0279923